(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Clinical trial NCT04411472 · TERMINATED

Trial details

NCT number: NCT04411472
Sponsor: AM-Pharma
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Kidney Injury Due to Sepsis

Start date: 2020-11-02
Primary completion: 2022-08-18
Enrollment: 676

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.